Open Source Marketing: BIO Urges Members To Adopt PhRMA’s Code
Executive Summary
The Biotechnology Industry Organization has adopted a broad policy statement that embraces the PhRMA marketing code that it initially had trepidations about
You may also be interested in...
BIO Continues To Mull PhRMA’s Marketing Code
Limits on physician interactions might not be appropriate when trying to educate doctors on complex, large-molecule products, the biotech group believes.
PhRMA’s Cap On Speaker Reimbursement Illustrates Code’s Balancing Act
The recommendations on industry-supported speakers in PhRMA's Code on Interactions with Healthcare Professionals illustrate the balance struck by the recent revisions to the document
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.